In light of evidence that deficits in BDNF expression and TrkB signaling contribute to neurological dysfunction in mouse models of RTT (Katz, 2014), we next examined whether or not chronic treatment of Mecp2 mutant mice with PTX-BD4-3 would ameliorate disease phenotypes. The gene discussed is NTRK2; the disease is Rett syndrome.